Stefano Todde’s Post

Yesterday, countries have adopted the AMR political declaration that sets out a target to reduce deaths associated with bacterial AMR annually by 10% by 2030. The declaration also calls for US$100 million in catalytic funding, and sets out ambitious targets, including: - At least 70% of antibiotics used for human health globally should belong to the WHO Access group antibiotics. - 100% of countries should have basic water, sanitation, hygiene and waste management services in all health care facilities - 90% of countries should meet all WHO’s minimum requirements for IPC programmes by 2030. Now it’s time to deliver. Hope the upcoming interministerial meeting in Jeddah, Saudi Arabia will help us move from “declaration to implementation”.

The rise of antibiotic-resistant bacteria is one of the greatest threats to #GlobalHealth, undermining treatment options for those who need them most. 🦠 To combat this, we need urgent action to support the development of new antibiotics. This includes fostering innovation, driving partnerships, and ensuring equitable access to these life-saving medicines. Learn more about how we can work together to tackle this critical challenge: https://lnkd.in/e6fYU6Zy #beatAMR #NewAntibioticsNow

According to the World Health Organization (WHO), antimicrobial resistance (AMR) has been declared a top 10 global public health threat and is expected to get worse unless action is taken. Join us for a live webinar on World Environment Day (5th June) exploring AMR and the environment: The challenge of manufacturing and procuring antibiotics responsibly. With insights and perspectives from a wide range of experts, this webinar will focus on the connection between human health and environmental pillars of One Health, and its link to the manufacturing of antibiotics. Find out more and register here: https://lnkd.in/emtrHkQq #AntimicrobialResistance #AMR #PublicHealth #SustainableHealthcare #WorldEnvironmentDay

In today’s #BhekisisaInYourInbox, Thatego Mashabela shares a Global Health NOW article on how drug companies need to improve antibiotic development. https://lnkd.in/dYbibhjP

India takes a major leap forward in the global fight against antimicrobial resistance with the launch of its first indigenous antibiotic drug, Nafithromycin. This game-changing innovation offers a safer, more effective, and tolerable solution to treat severe, drug-resistant pneumonia - a testament to the country's scientific advancements and commitment to tackling this critical public health challenge. Source - https://lnkd.in/dKkFJV7D. #IndigenousInnovation #AntimicrobialResistance #DrugResistantInfections #Nafithromycin #MedicalBreakthrough #PublicHealthSolution #IndiaScience #BiotechInnovation

#ICYMI our latest webinar is now available to watch on-demand ⏯ https://gag.gl/B8lKJN AMR threatens to undermine the basis of modern medicine, but also has implications beyond human health, including domestic and wild animals, plants and the wider environment (including ecosystems). Accordingly, a “One Health” approach is necessary to prevent and control AMR. This webinar features expert insights and perspectives on the connection between human health and environmental pillars of One Health, and its link to the manufacturing of antibiotics. #AntimicrobialResistance #AMR #PublicHealth #SustainableHealthcare

Antimicrobial Resistance (AMR) Multi-Stakeholder Partnership Platform calls upon UN Member States to agree upon actionable, measurable steps applying the One Health approach to ensure a healthier, more sustainable and resilient present and future where antimicrobials are preserved as critical life-saving medicines, equally accessible to everyone, everywhere.  https://lnkd.in/dFJiBk-i

🌍 Saving Lives: How Early Access Programs Address Antibiotic Resistance 🌍 Antibiotic resistance is now the third leading cause of death globally, claiming nearly 5 million lives annually. The impact is especially severe in low- and middle-income countries. A recent article in The Lancet estimated that there is the potential to save 92 million lives between 2025-2050 by improving access to antibiotics. Stuart Bell, EVP Inceptua Early Access and Estelle Canazilles, Senior Program Manager, Inceptua Early Access are taking a deeper dive into the challenges and describes how Early Access Programs help ensuring access to life saving medicines. Learn more – read the full article on our website: https://lnkd.in/d8Vjyhzy #AntibioticResistance #HealthcareInnovation #EarlyAccess #HelpingPharmaHelpingPatients

With growing antibiotic resistance, many health systems, particularly in low– and middle-income countries, do not have reliable access to effective antibiotics. SECURE is expanding sustainable access to antibiotics: https://lnkd.in/ed2hTj2y

According to the World Health Organization, antimicrobial resistance is a top 10 global public health threat. Across the world, societies are successfully increasing access to treatment for diseases and illnesses through the use of key antibiotics, leaning into the opportunity to create a more sustainable world. However, a lack of focus on environmental considerations when manufacturing antibiotics begins to threaten the miracles of modern medicine. AMR describes what happens when bacteria, viruses or parasites change and develop a resistance to the antibiotics designed to treat them. What can your organization do about it? For pharmaceutical manufacturers, the question is how best to manage and control waste streams across the global supply chain. Although manufacturing waste emissions aren’t the main source of antibiotics in our environment, some companies are proactively managing waste by taking a risk-based approach. BSI has partnered with the healthcare ecosystem to take concrete action and drive change on this public health threat, leveraging our expertise in standardization and independent certification. Find out more about the AMR Industry Alliance Manufacturing Standard in this blog from Courtney Soulsby, Global Director, Healthcare & Life Sciences: https://lnkd.in/e2z_hbwe #AntimicrobialResistance #AMR #PublicHealth #Antibiotics